Page last updated: 2024-08-21

2-aminopurine and diethylnitrosamine

2-aminopurine has been researched along with diethylnitrosamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, W; Grubinger, M; Gucky, T; Haider, C; Jorda, R; Kryštof, V; Miklos, W; Mikulits, W; Řezníčková, E; Rotheneder, H; Strnad, M; Weiss, TS; Zatloukal, M	1

Other Studies

1 other study(ies) available for 2-aminopurine and diethylnitrosamine

Article	Year
Novel inhibitors of cyclin-dependent kinases combat hepatocellular carcinoma without inducing chemoresistance. Molecular cancer therapeutics, 2013, Volume: 12, Issue:10 Topics: 2-Aminopurine; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Diethylnitrosamine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Primary Cell Culture; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2013

Article

Year

Novel inhibitors of cyclin-dependent kinases combat hepatocellular carcinoma without inducing chemoresistance.

Molecular cancer therapeutics, 2013, Volume: 12, Issue:10

Topics: 2-Aminopurine; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Diethylnitrosamine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Primary Cell Culture; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2013